AG真人官方

Sherwin-Williams (SHW) filed a Form 144 disclosing a planned open-market sale of 860 common shares through Fidelity Brokerage on 08/06/2025. At the latest closing price this equates to an approximate value of $301,301.

The company reports 249,333,316 shares outstanding, so the proposed sale represents roughly 0.0003 % of the float鈥攆ar too small to influence liquidity, ownership structure, or market price. The seller will fund the shares via a same-day option exercise originally granted on 10/16/2019; the filing shows no other insider sales in the past three months.

No financial results, guidance, or strategic information accompanies the notice. The document merely fulfills Rule 144 requirements and does not, by itself, signal a change in the firm鈥檚 fundamentals or outlook.

Milestone Scientific (MLSS) 8-K: On 31 Jul 2025 the Board appointed Eric Hines as President, Chief Executive Officer and director.

Compensation: Initial Term (31 Jul鈥�31 Dec 2025) base pay is $15 k/month; rate increases to $25 k/month from 1 Jan 2026 if both parties agree to continue employment. Hines also receives 2.0 million stock options at fair-market strike; 10 % vests immediately and 90 % vests in three equal annual instalments of 600 k shares.

An annual incentive bonus鈥攑erformance-based plus discretionary鈥攎ay be awarded by the Compensation Committee.

Background: Hines previously led North America for Ex Libris (2014-2021) and held senior sales roles at NICE Systems, AMDOCS Clarify CRM and others. He holds a BS in Chemistry (Wake Forest) and an MBA in International Business (Xavier).

A confirming press release (Exhibit 99.1) was issued 1 Aug 2025. No financial results or other material transactions were disclosed.

On 08/04/2025, Carvana Co. (CVNA) CEO, director and 10 % owner Ernest C. Garcia III filed a Form 4 showing the sale of 7,254 Class A shares through two family trusts. The trades were executed under a Rule 10b5-1 plan adopted 13 Dec 2024 and were split into multiple lots at prices ranging from $353.08-$366.29 (volume-weighted averages reported).

After the transactions, the Ernest Irrevocable 2004 Trust III holds 583,069 shares and the Ernest C. Garcia III Multi-Generational Trust III holds 683,070 shares. Garcia also reports 923,155 shares held directly, bringing total reported beneficial ownership to roughly 2.19 million shares. The divestiture equals about 0.3 % of his disclosed stake, and no derivative securities were involved.

The filing appears to reflect routine liquidity management rather than a strategic shift; however, investors may still view ongoing insider selling by the founder-CEO with caution.

agilon health, inc. (AGL) 鈥� Form 4, filed 08/05/2025

Chief Legal Officer Denise Zamore reported a Rule 16b-3 鈥淔鈥� transaction dated 08/01/2025. The issuer withheld 915 common shares at an indicated $1.70 per share to cover income-tax obligations arising from the net settlement of previously granted restricted stock units. Because the shares were withheld by the company rather than sold in the open market, Zamore鈥檚 underlying economic exposure to AGL stock is largely unchanged. Following the withholding, she directly owns 443,125 shares (including unvested RSUs); no derivative securities were acquired or disposed of. No other officers or directors were involved, and no additional transactions were disclosed.

The filing is routine and does not signal an intentional sale or purchase. Investors may view the update as neutral but can use it to monitor insider ownership trends and share-based compensation practices.

The Form 144 filing shows a Gevo, Inc. (GEVO) shareholder intends to sell up to 28,500 common shares through Stifel Nicolaus on Nasdaq. The block equals roughly 0.01 % of the 239,562,995 shares outstanding and carries an aggregate market value of $35,072, implying a reference price near $1.23 per share. The proposed sale date is 08/05/2025.

The shares were acquired on 08/03/2025 via restricted stock units and will be paid for in cash at settlement. The same seller, Kimberly Bowron, disposed of 35,688 shares during the prior three months for gross proceeds of $45,411. No material adverse information is asserted in the notice, and no additional company financial data are provided.

Form 4 highlights for Carvana Co. (CVNA): Executive Chairman and 10% owner Ernest C. Garcia II, together with his entity ECG II SPE, reported transactions dated 7/31-8/1/25.

• Dispositions: 106,624 Class A shares were sold under a Rule 10b5-1 plan at weighted-average prices of $365-413, generating 鈮� $40.6 million in gross proceeds.
• Conversions: 100,000 Class A Units of Carvana Group were exchanged for an equal number of Class A shares immediately prior to sale; 100,000 Class B shares were simultaneously cancelled.
• Post-trade ownership: Garcia now holds 0 Class A shares directly but retains 35.14 million Class B shares and 43.93 million exchangeable Class A Units. ECG II SPE additionally holds 8 million Class A Units (exchangeable for 6.4 million Class A shares).
• Plan status: All sales were pre-scheduled (10b5-1) to provide safe-harbor protection.

The filing signals continued insider liquidity but leaves Garcia鈥檚 voting control largely intact thanks to high-vote Class B stock and sizeable partnership units.

Carvana Co. (CVNA) 鈥� Form 4 insider activity dated 31 Jul 2025

Company founder and 10% owner Ernest C. Garcia II converted 125,000 Class A units of Carvana Group into 100,000 Class A shares; the related 100,000 Class B shares were automatically cancelled under the 2017 Exchange Agreement. On the same day, acting under a Rule 10b5-1 trading plan adopted 13 Dec 2024, Garcia sold 93,376 Class A shares in 24 separate trades at weighted-average prices between $383.45 and $407.86 (鈮� $395 blended), realizing roughly $37 million in gross proceeds.

After the transactions Garcia directly owns 6,624 Class A shares, 35.24 million Class B shares and 44.05 million Class A units; indirectly, his wholly-owned ECG II SPE, LLC holds a further 8 million Class B shares and 10 million Class A units. Although the sale represents a small fraction of his multi-class economic stake (<1 %), it introduces an incremental 100 k shares to the Class A float and may be viewed by investors as a liquidity-motivated reduction in common-stock exposure.

FirstCash Holdings, Inc. (FCFS) filed a Form 144 disclosing an insider鈥檚 intention to sell up to 6,000 common shares through J.P. Morgan Securities on or after 4 Aug 2025. At the filing鈥檚 stated aggregate value of $786,480, the sale represents roughly 0.01 % of the 44.36 million shares outstanding, making it immaterial to the company鈥檚 capital structure. The shares originated from four restricted-stock unit (RSU) vesting events completed between 2016 and 2023. No sales by the filer were reported in the previous three months, and the notice certifies the absence of undisclosed material information. Form 144 simply provides advance notice under Rule 144 and does not obligate the transaction. While investors sometimes view insider selling as a sentiment gauge, the small size and routine nature of this filing suggest minimal financial impact on FCFS.

Form 144 filed for Eagle Bancorp Montana, Inc. (EBMT) discloses a proposed sale of 3,800 common shares, to be executed through Computershare on or after 08/04/2025. The shares were acquired via stock-incentive compensation grants dated 11/01/2017 and have an aggregate market value of $59,774. With 7,952,177 shares outstanding, the planned disposition represents roughly 0.05 % of total shares, indicating an immaterial effect on the public float. No other sales were reported in the past three months, and the filer certifies no undisclosed adverse information. The notice is procedural and does not include earnings or operational data; investors typically view such small Form 144 filings as neutral unless they signal broader insider-selling trends.